Dark
Streaming/Mobile
Old Site
Home
Daily
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:52:45 EST Tue 07 Feb 2023
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login ID:
Password:
Save
Z:LLY
- ELI LILLY AND COMPANY -
http://www.lilly.com
10:52:45 EST
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
LLY
- Z
6.6
334.02
·
334.30
1.0
334.16
-3.50
-1.0
434.9
144,926
5,230
336.63
336.63
332.69
384.44 231.87
10:32:59
10:00
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 5230
More trades...
Time ET
Ex
Price
Change
Volume
10:33:07
Z
334.463
-3.197
9
10:33:07
Z
334.50
-3.16
1
10:33:07
Z
334.31
-3.35
70
10:33:05
Z
334.315
-3.345
104
10:33:05
Z
334.315
-3.345
100
10:33:01
Z
334.25
-3.41
8
10:33:00
Z
334.24
-3.42
20
10:33:00
Z
334.30
-3.36
10
10:33:00
Z
334.31
-3.35
2
10:33:00
Z
334.31
-3.35
80
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2023-02-07 10:00
U:LLY
News Release
200
Lilly to Participate in SVB Securities Global Biopharma Conference
2023-02-03 10:00
U:LLY
News Release
200
Lilly to Participate in Guggenheim Oncology Conference
2023-02-02 06:45
U:LLY
News Release
200
Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook
2023-01-27 14:07
U:LLY
News Release
200
U.S. FDA Approves Jaypirca ¢ „ ¢ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor
2023-01-26 10:00
U:LLY
News Release
200
Lilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity
2023-01-24 06:30
U:LLY
News Release
200
Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
2023-01-20 09:00
U:LLY
News Release
200
US FDA accepts supplemental New Drug Application for Jardiance ‚ ® for adults with chronic kidney disease
2023-01-19 18:00
U:LLY
News Release
200
U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of Donanemab
2023-01-19 10:00
U:LLY
News Release
200
Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement